波士顿大学全球发展政策研究中心：2025年关于15个中等收入国家国家专利立法中强制许可条款的报告：内容分析和建议（英文版）

The access to medicines discourse over the past 30 years has highlighted the myriad of obstacles to access experienced by low- and middle-income countries (LMICs). Already plagued by over-taxed health services systems, a limited health care workforce, and other resource constraints, in the mid-1990s these countries faced a new constraint in the form of the World Trade Organization’s (WTO) Agreement on Trade-Related Aspects of Intellectual Property Rights (hereafter referred to as the TRIPS Ag